from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1986/-

LFCtreatmentdescriptionclass of inhibitor

0.987

Amikacinug/mL Amikacintranslation

1.838

Cap5-10ug/mL Capreomycintranslation

2.943

Rox10-50 ug/mL Roxithromycintranslation

0.197

SM2-5 ug/mL Streptomycintranslation

1.540

Tet5-10 ug/mL Tetracyclinetranslation

-0.238

Rif0.2-5ug/mL Rifampicintranscription

-0.168

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.148

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.273

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.300

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.178

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.493

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.659

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

5.259

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.173

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.847

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.253

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.223

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.011

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.080

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.301

Nigericin50 uM Nigericinrespiration

-0.326

TRC10-150 ug/mL Triclosanrespiration

0.128

TRZ10-25 ug/mL Thioridazinerespiration

1.375

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.162

menadione6-10 ug/mL Menadionerespiration

0.003

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.865

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.036

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.816

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.128

NRP_1Non-replicating persistence stage 1dosRassociated

-0.482

Amp0.2mg/mL AmpicillincellWall

-0.370

Cephalexin20-100 ug/mL CephalexincellWall

-0.316

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.493

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.350

EMB10-20 ug/mL EthambutolcellWall

-0.502

Eta12-40 ug/mL EthionamidecellWall

-0.040

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.379

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.358

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.452

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.553

BZA0.12 mg/mL BenzamidearomaticAmides

0.054

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.213

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.036

H2O24 mM hydrogen peroxideDNAdamaging

-0.080

Levo10 ug/mL LevofloxacinDNAdamaging

-0.153

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.354

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.209

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.478

UVUV-irradiationDNAdamaging

0.324

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.069

Antimycin12.5-50 ug/mL Antimycin A?

0.003

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.556

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.753

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.410

PA8240.2-2 ug/mL PA-824?

-0.257

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.465

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.401

Verapamil50 uM Verapamil?

-0.439

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.196

methoxatin10-20 ug/mL Methoxatin?